Mini CV
- Depuis 2015: Praticien hospitalier. CHU de Toulouse
- 2009-2015 : Praticien attaché. CHU Necker-Enfants malades. Paris
- 2011-2014 : Doctorat en sciences. « Métagénomique bactérienne de l’hidrosadénite suppurée », sous la direction du Pr X. Nassif (laboratoire INSERM U1002 Pathogénie des infections systémiques, faculté de médecine Necker), Thèse soutenue le 25 novembre 2014.
- 2008 : 2e année de master Biologie Moléculaire et Cellulaire, spécialité Microbiologie – parcours Microbiologie fondamentale, Travail de recherche effectué dans l’unité des Interactions bactéries-cellules du Pr P. Cossart (Institut Pasteur, Paris) : « Contribution à l’étude des ARN non codants et de la régulation dépendantes des ARN chez Listeria monocytogenes ».
Recherche/projet research/project
ENTEROBACTERIAL INFECTIONS AND DYSBIOSIS IN METABOLIC DISEASES, GUT INFLAMMATION AND CANCER
Production scientifique scientific production
Revillet H, Poirée S, Duchatelet S, Jullien V, Hovnanian A, Lortholary O, Nassif X, Nassif A. Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients., J Antimicrob Chemother. 2016 Feb;71(2):513-20
[2] Nikolakis G, Join-Lambert O, Karagiannidis I, Guet-Revillet H, Zouboulis CC, Nassif A. Bacteriology of hidradenitis suppurativa/acne inversa: A review., J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S12-8.
[3] Delage M, Guet-Revillet H, Duchatelet S, Hovnanian A, Nassif X, Nassif A, Join-Lambert O. Deciphering the microbiology of hidradenitis suppurativa: a step forward towards understanding an enigmatic inflammatory skin disease., Exp Dermatol. 2015 Oct;24(10):736-7.
[4] H. Guet-Revillet, H. Coignard-Biehler, J.-P. Jais, G. Quesne, E. Frapy, S. Poirée, A.-S. Le Guern, A. Le Flèche-Matéos, A. Hovnanian, P.-H. Consigny, O. Lortholary, X. Nassif, A. Nassif, et O. Join-Lambert, Bacterial pathogens associated with hidradenitis suppurativa, France. Emerg Infect Dis, vol. 20, no. 12, pp. 1990–1998, Dec 2014.
[5] H. Guet-Revillet, A. Emirian, M. Groh, B. Nebbad-Lechani, E. Weiss, O. Join-Lambert, E. Bille, V. Jullien, et J. R. Zahar. Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli. Antimicrob Agents Chemother, vol. 58, no. 8, pp. 4899–4901, Aug 2014.
[6] O. Join-Lambert, F. Ribadeau-Dumas, V. Jullien, M.-D. Kitzis, J.-P. Jais, H. Coignard-Biehler, H. Guet-Revillet, P.-H. Consigny, M. Delage, X. Nassif, O. Lortholary, et A. Nassif. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination. Eur J Dermatol, Jan 2014.
[7] H. Guet-Revillet, C. Levy, I. Andriantahina, N. Kalach, M.-H. Pierre, A. Elbez-Rubinstein, C. Boniface, P. Berche, R. Cohen, et A. Ferroni. Paediatric epidemiology of Pasteurella multocida meningitis in France and review of the literature. Eur J Clin Microbiol Infect Dis, vol. 32, no. 9, pp. 1111–1120, Sep 2013.
[8] H. Guet-Revillet, A. Le Monnier, N. Breton, P. Descamps, H. Lecuyer, I. Alaabouche, C. Bureau, X. Nassif, et J.-R. Zahar. Environmental contamination with extended-spectrum β-lactamases: is there any difference between Escherichia coli and Klebsiella spp? Am J Infect Control, vol. 40, no. 9, pp. 845–848, Nov 2012.
[9] E. Farfour, J. Leto, M. Barritault, C. Barberis, J. Meyer, B. Dauphin, A.-S. Le Guern, A. Le Flèche, E. Badell, N. Guiso, A. Leclercq, A. L. Monnier, M. Lecuit, V. Rodriguez-Nava, E. Bergeron, J. Raymond, S. Vimont, E. Bille, E. Carbonnelle, H. Guet-Revillet, H. Lécuyer, J.-L. Beretti, C. Vay, P. Berche, A. Ferroni, X. Nassif, et O. Join-Lambert. Evaluation of the Andromas matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of aerobically growing Gram-positive bacilli. J Clin Microbiol, vol. 50, no. 8, pp. 2702–2707, Aug 2012.
[10] R. A. Bonnin, A. A. Ocampo-Sosa, L. Poirel, H. Guet-Revillet, et P. Nordmann. Biochemical and genetic characterization of carbapenem-hydrolyzing β-lactamase OXA-229 from Acinetobacter bereziniae. Antimicrob Agents Chemother, vol. 56, no. 7, pp. 3923–3927, Jul 2012.
[11] O. Join-Lambert, H. Coignard, J.-P. Jais, H. Guet-Revillet, S. Poirée, S. Fraitag, V. Jullien, F. Ribadeau-Dumas, J. Thèze, A.-S. Le Guern, S. Behillil, A. Le Flèche, P. Berche, P. H. Consigny, O. Lortholary, X. Nassif, et A. Nassif. Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. Dermatology, vol. 222, no. 1, pp. 49–58, Feb 2011.
[12] A. Lotz, A. Ferroni, J.-L. Beretti, B. Dauphin, E. Carbonnelle, H. Guet-Revillet, N. Veziris, B. Heym, V. Jarlier, J.-L. Gaillard, C. Pierre-Audigier, E. Frapy, P. Berche, X. Nassif, et E. Bille. Rapid identification of mycobacterial whole cells in solid and liquid culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol, vol. 48, no. 12, pp. 4481–4486, Dec 2010.
[13] A. Toledo-Arana, O. Dussurget, G. Nikitas, N. Sesto, H. Guet-Revillet, D. Balestrino, E. Loh, J. Gripenland, T. Tiensuu, K. Vaitkevicius, M. Barthelemy, M. Vergassola, M.-A. Nahori, G. Soubigou, B. Régnault, J.-Y. Coppée, M. Lecuit, J. Johansson, et P. Cossart. The Listeria transcriptional landscape from saprophytism to virulence. Nature, vol. 459, no. 7249, pp. 950–956, Jun 2009.
[2] Nikolakis G, Join-Lambert O, Karagiannidis I, Guet-Revillet H, Zouboulis CC, Nassif A. Bacteriology of hidradenitis suppurativa/acne inversa: A review., J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S12-8.
[3] Delage M, Guet-Revillet H, Duchatelet S, Hovnanian A, Nassif X, Nassif A, Join-Lambert O. Deciphering the microbiology of hidradenitis suppurativa: a step forward towards understanding an enigmatic inflammatory skin disease., Exp Dermatol. 2015 Oct;24(10):736-7.
[4] H. Guet-Revillet, H. Coignard-Biehler, J.-P. Jais, G. Quesne, E. Frapy, S. Poirée, A.-S. Le Guern, A. Le Flèche-Matéos, A. Hovnanian, P.-H. Consigny, O. Lortholary, X. Nassif, A. Nassif, et O. Join-Lambert, Bacterial pathogens associated with hidradenitis suppurativa, France. Emerg Infect Dis, vol. 20, no. 12, pp. 1990–1998, Dec 2014.
[5] H. Guet-Revillet, A. Emirian, M. Groh, B. Nebbad-Lechani, E. Weiss, O. Join-Lambert, E. Bille, V. Jullien, et J. R. Zahar. Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli. Antimicrob Agents Chemother, vol. 58, no. 8, pp. 4899–4901, Aug 2014.
[6] O. Join-Lambert, F. Ribadeau-Dumas, V. Jullien, M.-D. Kitzis, J.-P. Jais, H. Coignard-Biehler, H. Guet-Revillet, P.-H. Consigny, M. Delage, X. Nassif, O. Lortholary, et A. Nassif. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination. Eur J Dermatol, Jan 2014.
[7] H. Guet-Revillet, C. Levy, I. Andriantahina, N. Kalach, M.-H. Pierre, A. Elbez-Rubinstein, C. Boniface, P. Berche, R. Cohen, et A. Ferroni. Paediatric epidemiology of Pasteurella multocida meningitis in France and review of the literature. Eur J Clin Microbiol Infect Dis, vol. 32, no. 9, pp. 1111–1120, Sep 2013.
[8] H. Guet-Revillet, A. Le Monnier, N. Breton, P. Descamps, H. Lecuyer, I. Alaabouche, C. Bureau, X. Nassif, et J.-R. Zahar. Environmental contamination with extended-spectrum β-lactamases: is there any difference between Escherichia coli and Klebsiella spp? Am J Infect Control, vol. 40, no. 9, pp. 845–848, Nov 2012.
[9] E. Farfour, J. Leto, M. Barritault, C. Barberis, J. Meyer, B. Dauphin, A.-S. Le Guern, A. Le Flèche, E. Badell, N. Guiso, A. Leclercq, A. L. Monnier, M. Lecuit, V. Rodriguez-Nava, E. Bergeron, J. Raymond, S. Vimont, E. Bille, E. Carbonnelle, H. Guet-Revillet, H. Lécuyer, J.-L. Beretti, C. Vay, P. Berche, A. Ferroni, X. Nassif, et O. Join-Lambert. Evaluation of the Andromas matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of aerobically growing Gram-positive bacilli. J Clin Microbiol, vol. 50, no. 8, pp. 2702–2707, Aug 2012.
[10] R. A. Bonnin, A. A. Ocampo-Sosa, L. Poirel, H. Guet-Revillet, et P. Nordmann. Biochemical and genetic characterization of carbapenem-hydrolyzing β-lactamase OXA-229 from Acinetobacter bereziniae. Antimicrob Agents Chemother, vol. 56, no. 7, pp. 3923–3927, Jul 2012.
[11] O. Join-Lambert, H. Coignard, J.-P. Jais, H. Guet-Revillet, S. Poirée, S. Fraitag, V. Jullien, F. Ribadeau-Dumas, J. Thèze, A.-S. Le Guern, S. Behillil, A. Le Flèche, P. Berche, P. H. Consigny, O. Lortholary, X. Nassif, et A. Nassif. Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. Dermatology, vol. 222, no. 1, pp. 49–58, Feb 2011.
[12] A. Lotz, A. Ferroni, J.-L. Beretti, B. Dauphin, E. Carbonnelle, H. Guet-Revillet, N. Veziris, B. Heym, V. Jarlier, J.-L. Gaillard, C. Pierre-Audigier, E. Frapy, P. Berche, X. Nassif, et E. Bille. Rapid identification of mycobacterial whole cells in solid and liquid culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol, vol. 48, no. 12, pp. 4481–4486, Dec 2010.
[13] A. Toledo-Arana, O. Dussurget, G. Nikitas, N. Sesto, H. Guet-Revillet, D. Balestrino, E. Loh, J. Gripenland, T. Tiensuu, K. Vaitkevicius, M. Barthelemy, M. Vergassola, M.-A. Nahori, G. Soubigou, B. Régnault, J.-Y. Coppée, M. Lecuit, J. Johansson, et P. Cossart. The Listeria transcriptional landscape from saprophytism to virulence. Nature, vol. 459, no. 7249, pp. 950–956, Jun 2009.